# 500mg Fulvestrant Versus Exemestane in MBC

> **NCT03575260** · — · COMPLETED · sponsor: **Fudan University** · enrollment: 120 (actual)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03575260
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-01
- **Primary completion:** 2019-01-10
- **Final completion:** 2019-01-15
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2019-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03575260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03575260, "500mg Fulvestrant Versus Exemestane in MBC". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03575260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*